Genetic risk models, including PREMMplus and BOADICEA/CanRisk, refine breast cancer risk assessment by incorporating genetic status and polygenic risk scores. Challenges in classifying gene variants, ...
Accurate interpretation of cancer genomics depends on standardized disease classification, tumor characterization and variant ...
Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2–/ERBB2-Altered Advanced Biliary Tract Cancers Despite this apparent fracture in our field, these two lymphoma ...